Johnson & Johnson - 53 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of November 28, 2023 is 151.63.
  • The all-time high Johnson & Johnson stock closing price was 177.11 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 181.04, which is 19.4% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 144.95, which is 4.4% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 162.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 158.0089 172.9899 174.9898 144.4533 151.6300 -11.58%
2022 165.2950 162.2816 177.1124 150.5756 171.4949 5.97%
2021 154.5437 144.4005 167.6634 142.1169 161.8369 11.45%
2020 132.6763 131.0871 145.2124 100.4582 145.2124 10.85%
2019 119.9995 112.4187 131.5092 110.6323 130.9973 15.35%
2018 115.4557 119.2910 130.0977 103.7143 113.5627 -5.14%
2017 109.7796 96.7532 122.4268 93.3454 119.7108 24.40%
2016 93.6117 81.6221 103.3273 77.7798 96.2270 15.32%
2015 79.8161 82.4471 85.4969 73.1665 83.4417 1.16%
2014 78.4729 69.8700 85.6023 66.4851 82.4865 17.34%
2013 64.8854 52.7741 73.4007 52.6996 70.2998 34.62%
2012 48.9658 47.3370 53.5560 45.2165 52.2228 10.83%
2011 44.8233 43.5525 47.9280 40.3370 47.1215 9.89%
2010 42.3030 43.3119 44.5554 38.8277 42.8800 -0.58%
2009 38.0833 39.2916 43.4994 30.4436 43.1311 11.28%
2008 41.4336 41.5274 46.4212 35.8451 38.7604 -7.77%
2007 39.7847 40.7945 43.0963 37.0780 42.0252 3.61%
2006 37.7705 36.9903 42.2129 34.0914 40.5610 12.44%
2005 38.4304 37.0192 41.0195 36.0360 36.0720 -3.36%
2004 32.5904 29.8205 37.5254 28.6992 37.3253 25.17%
2003 30.0898 31.3835 33.4109 28.0002 29.8205 -2.11%
2002 32.4636 32.8463 36.7609 23.5696 30.4646 -7.88%
2001 28.8814 28.1609 34.1165 23.0623 33.0701 13.97%
2000 24.5295 25.1543 29.0167 18.7580 29.0167 14.04%
1999 25.5208 22.3036 28.9497 20.7689 25.4436 12.46%
1998 20.1150 17.3221 24.0056 17.0398 22.6246 28.99%
1997 15.7759 13.0597 17.8226 13.0597 17.5404 34.31%
1996 12.6460 10.8956 14.1097 10.8956 13.0597 18.11%
1995 8.8297 6.9163 11.8332 6.8211 11.0573 59.14%
1994 5.8014 5.6045 7.0597 4.5801 6.9480 25.00%
1993 5.1382 5.9830 5.9830 4.3864 5.5586 -8.93%
1992 5.9118 6.6626 6.9078 5.1645 6.1038 -10.19%
1991 5.2788 4.0842 6.8555 3.8287 6.7962 62.34%
1990 3.6311 3.4215 4.2385 2.9712 4.1863 23.38%
1989 2.8307 2.3368 3.3929 2.3368 3.3929 42.64%
1988 2.2350 2.1299 2.4474 1.9184 2.3787 16.52%
1987 2.3331 1.8104 2.8371 1.7491 2.0415 15.79%
1986 1.6951 1.3642 1.9748 1.2556 1.7631 27.42%
1985 1.1559 0.9106 1.4397 0.8978 1.3837 49.85%
1984 0.8607 1.0095 1.0465 0.7094 0.9234 -8.53%
1983 1.1139 1.1940 1.2340 0.9692 1.0095 -15.66%
1982 0.9743 0.8623 1.2302 0.7698 1.1969 36.93%
1981 0.7940 0.7641 0.8944 0.6668 0.8741 14.55%
1980 0.5992 0.5711 0.7650 0.4982 0.7631 29.40%
1979 0.5291 0.5373 0.5953 0.4784 0.5897 10.49%
1978 0.5497 0.5309 0.6387 0.4692 0.5337 -1.77%
1977 0.4932 0.5419 0.5433 0.4367 0.5433 0.43%
1976 0.5952 0.6175 0.6595 0.4994 0.5410 -12.03%
1975 0.6069 0.5634 0.6753 0.5007 0.6150 12.00%
1974 0.6661 0.7527 0.8031 0.5087 0.5491 -27.70%
1973 0.7989 0.8617 0.8751 0.7039 0.7595 -13.21%
1972 0.7895 0.6530 0.8853 0.6338 0.8751 32.99%
1971 0.5674 0.3805 0.6606 0.3805 0.6580 73.71%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $360.875B $94.943B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $567.306B 100.95
Novo Nordisk (NVO) Denmark $464.863B 42.98
Merck (MRK) United States $260.194B 33.23
AbbVie (ABBV) United States $244.191B 11.60
Novartis AG (NVS) Switzerland $201.892B 14.03
AstraZeneca (AZN) United Kingdom $197.738B 17.72
Pfizer (PFE) United States $169.279B 10.45
Sanofi (SNY) $117.623B 10.64
Innoviva (INVA) United States $0.873B 7.87